These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29648594)

  • 1. Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area.
    Tavoschi L; Vroling H; Madeddu G; Babudieri S; Monarca R; Vonk Noordegraaf-Schouten M; Beer N; Gomes Dias J; O'Moore É; Hedrich D; Oordt-Speets A
    Epidemiol Rev; 2018 Jun; 40(1):105-120. PubMed ID: 29648594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic Models of Infectious Disease Transmission in Prisons and the General Population.
    Ndeffo-Mbah ML; Vigliotti VS; Skrip LA; Dolan K; Galvani AP
    Epidemiol Rev; 2018 Jun; 40(1):40-57. PubMed ID: 29566137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis and tuberculosis control in European prisons.
    Aerts A; Hauer B; Wanlin M; Veen J
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1215-23. PubMed ID: 17131779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries.
    Madeddu G; Vroling H; Oordt-Speets A; Babudieri S; O'Moore É; Noordegraaf MV; Monarca R; Lopalco PL; Hedrich D; Tavoschi L
    Vaccine; 2019 Aug; 37(35):4906-4919. PubMed ID: 31327651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA.
    Vroling H; Oordt-Speets AM; Madeddu G; Babudieri S; Monarca R; O'Moore E; Vonk Noordegraaf-Schouten M; Wolff H; Montanari M; Hedrich D; Tavoschi L
    J Viral Hepat; 2018 Dec; 25(12):1406-1422. PubMed ID: 30187607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers--California, 2012.
    Lucas KD; Eckert V; Behrends CN; Wheeler C; MacGowan RJ; Mohle-Boetani JC
    MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(7):178-81. PubMed ID: 26914322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review.
    Seedat F; Hargreaves S; Nellums LB; Ouyang J; Brown M; Friedland JS
    Lancet Infect Dis; 2018 Sep; 18(9):e259-e271. PubMed ID: 29778396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prison cell spatial density and infectious and communicable diseases: a systematic review.
    Simpson PL; Simpson M; Adily A; Grant L; Butler T
    BMJ Open; 2019 Jul; 9(7):e026806. PubMed ID: 31340959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of screening algorithms to identify persons with active pulmonary tuberculosis at prison entry: protocol of a systematic review and network meta-analysis.
    Pape S; Gulma K; Shivalli S; Cleenewerck de Kiev L
    J Med Life; 2022 Dec; 15(12):1464-1475. PubMed ID: 36762336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review.
    Kronfli N; Linthwaite B; Kouyoumdjian F; Klein MB; Lebouché B; Sebastiani G; Cox J
    Int J Drug Policy; 2018 Jul; 57():95-103. PubMed ID: 29715590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary women prisoners health experiences, unique prison health care needs and health care outcomes in sub Saharan Africa: a scoping review of extant literature.
    Van Hout MC; Mhlanga-Gunda R
    BMC Int Health Hum Rights; 2018 Aug; 18(1):31. PubMed ID: 30081894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey.
    Wali A; Khan D; Safdar N; Shawani Z; Fatima R; Yaqoob A; Qadir A; Ahmed S; Rashid H; Ahmed B; Khan S
    BMC Public Health; 2019 Dec; 19(1):1631. PubMed ID: 31801496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HCV in prisons in Wales, UK and the impact of moving to opt-out HCV testing.
    Perrett SE; Plimmer A; Shankar AG; Craine N
    J Public Health (Oxf); 2020 May; 42(2):423-428. PubMed ID: 32090269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for the detection, monitoring, and management of chronic non-communicable diseases in the prison population: an international systematic review.
    Hewson T; Minchin M; Lee K; Liu S; Wong E; Edge C; Hard J; Forsyth K; Senior J; Shaw J
    BMC Public Health; 2024 Jan; 24(1):292. PubMed ID: 38267909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opt-out HIV testing in prison: informed and voluntary?
    Rosen DL; Golin CE; Grodensky CA; May J; Bowling JM; DeVellis RF; White BL; Wohl DA
    AIDS Care; 2015; 27(5):545-54. PubMed ID: 25506799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward healthy prisons: the TECH model and its applications.
    Ross MW; Jo Harzke A
    Int J Prison Health; 2012; 8(1):16-26. PubMed ID: 25757858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding how, why, for whom, and under what circumstances opt-out blood-borne virus testing programmes work to increase test engagement and uptake within prison: a rapid-realist review.
    Francis-Graham S; Ekeke NA; Nelson CA; Lee TY; Haj SE; Rhodes T; Vindrola C; Colbourn T; Rosenberg W
    BMC Health Serv Res; 2019 Mar; 19(1):152. PubMed ID: 30849986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action.
    Nakitanda AO; Montanari L; Tavoschi L; Mozalevskis A; Duffell E
    BMC Public Health; 2020 Nov; 20(1):1670. PubMed ID: 33167912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and opportunities for the management of infectious diseases in Europes' prisons: evidence-based guidance.
    Tavoschi L; O'Moore É; Hedrich D
    Lancet Infect Dis; 2019 Jul; 19(7):e253-e258. PubMed ID: 30902441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.